Kelly Hanestad - Concepedia

Author

Kelly Hanestad

Amgen (United States)

Also Known As

Kelly Hanestad

Publications

513

Citations

H-Index

Concepts

All Affiliations

Amgen (United States)

About

Kelly Hanestad is an author at Amgen (United States) specializing in tumor biology, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	161
2	Natural Sciences	3	3	106
3	Biochemistry	2	2	81
4	Cell Biology	2	2	80
5	Chemical Biology	1	1	37

Kelly Hanestad

Publications

501

Citations

H-Index

Page 1

	Year	Citations
Engineered Human IgG Antibodies with Longer Serum Half-lives in Primates Paul R. Hinton, Mary G. Johlfs, Joanna M. Xiong, Journal of Biological Chemistry	2004	271
AMG 900, a Small-Molecule Inhibitor of Aurora Kinases, Potentiates the Activity of Microtubule-Targeting Agents in Human Metastatic Breast Cancer Models Tammy L. Bush, Marc Payton, Scott Heller, Molecular Cancer Therapeutics Amg 900Chemoprevention StrategyMedicineReceptor Tyrosine KinaseSmall Molecules	2013	55
Small-molecule inhibition of kinesin KIF18A reveals a mitotic vulnerability enriched in chromosomally unstable cancers Marc Payton, Brian Belmontes, Kelly Hanestad, Nature Cancer	2023	54
Discovery of <i>N</i>-(4-(3-(2-Aminopyrimidin-4-yl)pyridin-2-yloxy)phenyl)-4-(4-methylthiophen-2-yl)phthalazin-1-amine (AMG 900), A Highly Selective, Orally Bioavailable Inhibitor of Aurora Kinases with Activity against Multidrug-Resistant Cancer Cell Lines Stephanie Geuns-Meyer, Victor J. Cee, Holly L. Deak, Journal of Medicinal Chemistry PharmacotherapyPharmaceutical ChemistryTumor BiologyPhysical PropertiesMolecular Pharmacology	2015	44
Discovery of a Potent, Selective, and Orally Bioavailable Pyridinyl-Pyrimidine Phthalazine Aurora Kinase Inhibitor Victor J. Cee, Laurie B. Schenkel, Brian L. Hodous, Journal of Medicinal Chemistry Pharmaceutical ScienceChemoprevention StrategyKinase InhibitorsChemical BiologyTumor Biology	2010	37
Targeting the Mitotic Kinesin KIF18A in Chromosomally Unstable Cancers: Hit Optimization Toward an In Vivo Chemical Probe Nuria Tamayo, Matthew P. Bourbeau, Jennifer R. Allen, Journal of Medicinal Chemistry Chromosomal InstabilityMolecular BiologyCytoskeletonCell CycleCin Cancer Cells	2022	25
Dual Targeting of Aurora Kinases with AMG 900 Exhibits Potent Preclinical Activity Against Acute Myeloid Leukemia with Distinct Post-Mitotic Outcomes Marc Payton, Hung-Kam Cheung, Maria Stefania S. Ninniri, Molecular Cancer Therapeutics	2018	15

Page 1